Clinical Trial Update: Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of uproleselan in combination with chemotherapy for Chinese patients with relapsed/refractory acute mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Uproleselan (uproleselan)

Snippet

Sponsor: Apollomics Inc. | Conditions: Relapsed/Refractory AML | Phase 1 | Status: COMPLETED